Orbimed Advisors LLC Merck & Co., Inc. Transaction History

Orbimed Advisors LLC

  • $3.69 Billion
  • Q4 2024

A detailed history of Orbimed Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 829,900 shares of MRK stock, worth $77.3 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
829,900
Previous 1,316,000 36.94%
Holding current value
$77.3 Million
Previous $149 Million 44.76%
% of portfolio
2.24%
Previous 3.52%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$96.31 - $114.76 $46.8 Million - $55.8 Million
-486,100 Reduced 36.94%
829,900 $82.6 Million
Q1 2024

May 15, 2024
BUY
$113.24 - $131.95 $29.6 Million - $34.4 Million
261,000 Added 24.74%
1,316,000 $174 Million
Q3 2023

Nov 14, 2023
BUY
$102.95 - $114.33 $109 Million - $121 Million
1,055,000 New
1,055,000 $109 Million
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $131 Million - $147 Million
-1,779,300 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $141 Million - $177 Million
-1,953,100 Reduced 52.33%
1,779,300 $136 Million
Q1 2021

May 17, 2021
BUY
$68.86 - $81.11 $73.9 Million - $87 Million
1,073,100 Added 40.35%
3,732,400 $288 Million
Q4 2020

Feb 16, 2021
BUY
$71.77 - $79.65 $5.04 Million - $5.59 Million
70,200 Added 2.71%
2,659,300 $218 Million
Q1 2020

May 15, 2020
BUY
$63.36 - $87.82 $40.2 Million - $55.8 Million
635,000 Added 32.5%
2,589,100 $199 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $46.9 Million - $51.1 Million
-616,000 Reduced 23.97%
1,954,100 $164 Million
Q1 2019

May 15, 2019
BUY
$69.58 - $79.36 $5.23 Million - $5.96 Million
75,100 Added 3.01%
2,570,100 $214 Million
Q4 2018

Feb 14, 2019
SELL
$65.24 - $75.71 $68.5 Million - $79.5 Million
-1,049,400 Reduced 29.61%
2,495,000 $191 Million
Q3 2018

Nov 14, 2018
SELL
$57.69 - $67.84 $65.5 Million - $77 Million
-1,135,600 Reduced 24.26%
3,544,400 $251 Million
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $30.9 Million - $36.3 Million
-608,200 Reduced 11.5%
4,680,000 $284 Million
Q1 2018

May 15, 2018
BUY
$50.96 - $59.23 $84.7 Million - $98.5 Million
1,662,800 Added 45.87%
5,288,200 $288 Million
Q4 2017

Feb 14, 2018
SELL
$51.62 - $61.64 $96.1 Million - $115 Million
-1,861,600 Reduced 33.93%
3,625,400 $204 Million
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $322 Million - $346 Million
5,487,000
5,487,000 $351 Million

Others Institutions Holding MRK

# of Institutions
3,963
Shares Held
1.94B
Call Options Held
16M
Put Options Held
15M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $236B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email